Dow Down 0.40% Nasdaq Down 0.00%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
2.57 Down 0.03(1.15%) 12:52PM EDT - Nasdaq Real Time Price
Prev Close:2.60
Open:2.61
Bid:2.55 x 3600
Ask:2.56 x 500
1y Target Est:6.50
Beta:1.38
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:2.53 - 2.65
52wk Range:2.31 - 5.00
Volume:396,159
Avg Vol (3m):479,425
Market Cap:225.63M
P/E (ttm):N/A
EPS (ttm):-0.98
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RIGLDown 1.15%225.63M
AMGNDown 1.37%104.42B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):39.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.08
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback